Journal of Clinical Oncology, Vol 24, No 17 (June 10), 2006: pp. 2606-2611
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.06.1291
Clinical Implications of Human Papillomavirus in Head and Neck Cancers
Carole Fakhry,
Maura L. Gillison
From the Departments of Viral Oncology, Aerodigestive Malignancy, and Cancer Prevention and Control, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and the Departments of Epidemiology and Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Address reprint requests to Maura L. Gillison, MD, PhD, Cancer Research Building I, Room G91, 1650 Orleans St, Baltimore, MD 21231; e-mail: gillima{at}jhmi.edu
Human papillomavirus (HPV) is now recognized to play a role in the pathogenesis of a subset of head and neck squamous cell carcinomas (HNSCCs), particularly those that arise from the lingual and palatine tonsils within the oropharynx. High-risk HPV16 is identified in the overwhelming majority of HPV-positive tumors, which have molecular-genetic alterations indicative of viral oncogene function. Measures of HPV exposure, including sexual behaviors, seropositivity to HPV16, and oral, high-risk HPV infection, are associated with increased risk for oropharyngeal cancer. HPV infection may be altering the demographics of HNSCC patients, as these patients tend to be younger, nonsmokers, and nondrinkers. There is sufficient evidence to conclude that a diagnosis of HPV-positive HNSCC has significant prognostic implications; these patients have at least half the risk of death from HNSCC when compared with the HPV-negative patient. The HPV etiology of these tumors may have future clinical implications for the diagnosis, therapy, screening, and prevention of HNSCC.
Supported in part by National Institute for Dental and Craniofacial Research Grant No. DE016631-02.
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
This article has been cited by other articles:

|
 |

|
 |
 
F. P. Worden, B. Kumar, J. S. Lee, G. T. Wolf, K. G. Cordell, J. M.G. Taylor, S. G. Urba, A. Eisbruch, T. N. Teknos, D. B. Chepeha, et al.
Chemoselection As a Strategy for Organ Preservation in Advanced Oropharynx Cancer: Response and Survival Positively Associated With HPV16 Copy Number
J. Clin. Oncol.,
July 1, 2008;
26(19):
3138 - 3146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kumar, K. G. Cordell, J. S. Lee, F. P. Worden, M. E. Prince, H. H. Tran, G. T. Wolf, S. G. Urba, D. B. Chepeha, T. N. Teknos, et al.
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer
J. Clin. Oncol.,
July 1, 2008;
26(19):
3128 - 3137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Singh and D. G. Pfister
Individualized Treatment Selection in Patients With Head and Neck Cancer: Do Molecular Markers Meet the Challenge?
J. Clin. Oncol.,
July 1, 2008;
26(19):
3114 - 3116.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Marsit, C. C. Black, M. R. Posner, and K. T. Kelsey
A Genotype-Phenotype Examination of Cyclin D1 on Risk and Outcome of Squamous Cell Carcinoma of the Head and Neck
Clin. Cancer Res.,
April 15, 2008;
14(8):
2371 - 2377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ji, A. S. Neumann, E. M. Sturgis, K. Adler-Storthz, K. R. Dahlstrom, J. T. Schiller, Q. Wei, and G. Li
p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers
Carcinogenesis,
April 1, 2008;
29(4):
875 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Chaturvedi, E. A. Engels, W. F. Anderson, and M. L. Gillison
Incidence Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas in the United States
J. Clin. Oncol.,
February 1, 2008;
26(4):
612 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Gillison
Human Papillomavirus and Prognosis of Oropharyngeal Squamous Cell Carcinoma: Implications for Clinical Research in Head and Neck Cancers
J. Clin. Oncol.,
December 20, 2006;
24(36):
5623 - 5625.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Perrone, S. Suardi, E. Pastore, P. Casieri, M. Orsenigo, S. Caramuta, G. Dagrada, M. Losa, L. Licitra, P. Bossi, et al.
Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma.
Clin. Cancer Res.,
November 15, 2006;
12(22):
6643 - 6651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Forastiere, A. Trotti, D. G. Pfister, and J. R. Grandis
Head and Neck Cancer: Recent Advances and New Standards of Care
J. Clin. Oncol.,
June 10, 2006;
24(17):
2603 - 2605.
[Full Text]
[PDF]
|
 |
|
|